NCT01806064 2020-10-19Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell CarcinomaTracon Pharmaceuticals Inc.Phase 1/2 Terminated173 enrolled 17 charts
NCT01727089 2018-08-28Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney CancerNational Cancer Institute (NCI)Phase 2 Completed59 enrolled 12 charts